ATE362991T1 - Kondensierte plasmid-liposome komplex zur transfektion - Google Patents
Kondensierte plasmid-liposome komplex zur transfektionInfo
- Publication number
- ATE362991T1 ATE362991T1 AT98949342T AT98949342T ATE362991T1 AT E362991 T1 ATE362991 T1 AT E362991T1 AT 98949342 T AT98949342 T AT 98949342T AT 98949342 T AT98949342 T AT 98949342T AT E362991 T1 ATE362991 T1 AT E362991T1
- Authority
- AT
- Austria
- Prior art keywords
- transfection
- plasmid
- liposome complex
- selecting
- condensed plasmid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/827,236 US5851818A (en) | 1996-05-31 | 1997-03-28 | Condensed plasmid-liposome complex for transfection |
PCT/US1998/019067 WO2000015825A1 (en) | 1997-03-28 | 1998-09-11 | Condensed plasmid-liposome complex for transfection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE362991T1 true ATE362991T1 (de) | 2007-06-15 |
Family
ID=26794355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98949342T ATE362991T1 (de) | 1997-03-28 | 1998-09-11 | Kondensierte plasmid-liposome komplex zur transfektion |
Country Status (10)
Country | Link |
---|---|
US (1) | US5851818A (de) |
EP (1) | EP1109926B1 (de) |
JP (1) | JP2002525270A (de) |
AT (1) | ATE362991T1 (de) |
AU (1) | AU9568698A (de) |
CA (1) | CA2342292A1 (de) |
DE (1) | DE69837819T2 (de) |
ES (1) | ES2286857T3 (de) |
HK (1) | HK1039633A1 (de) |
WO (1) | WO2000015825A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326356B1 (en) * | 1996-10-18 | 2001-12-04 | Board Of Regents, The University Of Texas System | Suppression of neu overexpression using a mini-E1A gene |
US6133026A (en) * | 1996-05-31 | 2000-10-17 | Sequus Pharmaceuticals, Inc. | Condensed plasmid-liposome complex for transfection |
US5851818A (en) * | 1996-05-31 | 1998-12-22 | Sequus Pharmaceuticals, Inc. | Condensed plasmid-liposome complex for transfection |
US6071533A (en) | 1996-11-12 | 2000-06-06 | The Regents Of The University Of California | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
US6749863B1 (en) * | 1997-11-19 | 2004-06-15 | Georgetown University | Targeted liposome gene delivery |
ATE511543T1 (de) * | 1999-02-22 | 2011-06-15 | Univ Georgetown | Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung |
US7112337B2 (en) * | 1999-04-23 | 2006-09-26 | Alza Corporation | Liposome composition for delivery of nucleic acid |
JP2003509060A (ja) * | 1999-09-17 | 2003-03-11 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | 逆トランスフェクション方法 |
US20020006664A1 (en) * | 1999-09-17 | 2002-01-17 | Sabatini David M. | Arrayed transfection method and uses related thereto |
US20040197390A1 (en) * | 2001-05-29 | 2004-10-07 | Shi-Kun Huang | Neutral-cationic lipid for systemic delivery of factor VIII gene |
US8143195B2 (en) * | 2000-01-24 | 2012-03-27 | Yingjian Wang | Arrays for bringing two or more reagents in contact with one or more biological targets and methods for making and using the arrays |
US7429466B2 (en) * | 2000-01-24 | 2008-09-30 | Hypromatrix, Inc | Methods and arrays for detecting biological molecules |
WO2003000291A1 (en) * | 2001-06-22 | 2003-01-03 | Techno Network Shikoku Co., Ltd. | Lipid vesicles, process for producing lipid vesicles and method of immobilizing gene on lipid vesicles |
US6670129B2 (en) | 2001-09-24 | 2003-12-30 | Corning Incorporated | Cell transfection apparatus and methods for making and using the cell transfection apparatus |
EP3100719A3 (de) * | 2002-05-15 | 2017-02-22 | California Pacific Medical Center | Zuführung von nukleinsäureähnlichen verbindungen |
AU2003259827B2 (en) | 2002-08-12 | 2008-09-04 | Dynavax Technologies Corporation | Immunomodulatory compositions, methods of making, and methods of use thereof |
EP1613285A2 (de) | 2003-03-31 | 2006-01-11 | Alza Corporation | Fettpartikel mit asymmetrischer lipid-beschichtung und herstellungsverfahren dafür |
EP1691780A2 (de) * | 2003-11-21 | 2006-08-23 | Alza Corporation | Durch liposom-dna-komplex vermittelte genzufuhr mit spaltbarer peg-oberflächenmodifikation |
US20060211004A1 (en) | 2005-02-15 | 2006-09-21 | Ilsley Diane D | Methods and compositions for determining non-specific cytotoxicity of a transfection agent |
JP4919397B2 (ja) * | 2006-06-30 | 2012-04-18 | 北海道システム・サイエンス株式会社 | 核酸導入用組成物 |
JP4510842B2 (ja) * | 2007-03-26 | 2010-07-28 | キヤノン株式会社 | ポリヒドロキシアルカノエート被覆リポソーム |
AU2014233428B2 (en) | 2013-03-15 | 2019-09-19 | Loma Linda University | Treatment of autoimmune diseases |
RU2589280C1 (ru) * | 2015-02-09 | 2016-07-10 | Государственное автономное научное учреждение Республики Башкортостан "Центр аграрных исследований" | Средство с липосомами, содержащими глутаминовую кислоту и экстракт прополиса, обладающее ноотропной активностью |
CN109288794B (zh) * | 2018-11-19 | 2021-02-23 | 上海交通大学 | 一种蜂毒素脂质体纳米制剂及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187260A (en) * | 1988-09-06 | 1993-02-16 | Sharifa Karali | Process for the preparation of a high purity protamine-DNA complex and process for use of same |
US5614503A (en) * | 1993-11-12 | 1997-03-25 | Aronex Pharmaceuticals, Inc. | Amphipathic nucleic acid transporter |
US5851818A (en) * | 1996-05-31 | 1998-12-22 | Sequus Pharmaceuticals, Inc. | Condensed plasmid-liposome complex for transfection |
-
1997
- 1997-03-28 US US08/827,236 patent/US5851818A/en not_active Expired - Lifetime
-
1998
- 1998-09-11 EP EP98949342A patent/EP1109926B1/de not_active Expired - Lifetime
- 1998-09-11 JP JP2000570352A patent/JP2002525270A/ja not_active Withdrawn
- 1998-09-11 AT AT98949342T patent/ATE362991T1/de not_active IP Right Cessation
- 1998-09-11 WO PCT/US1998/019067 patent/WO2000015825A1/en active IP Right Grant
- 1998-09-11 DE DE69837819T patent/DE69837819T2/de not_active Expired - Fee Related
- 1998-09-11 AU AU95686/98A patent/AU9568698A/en not_active Abandoned
- 1998-09-11 CA CA002342292A patent/CA2342292A1/en not_active Abandoned
- 1998-09-11 ES ES98949342T patent/ES2286857T3/es not_active Expired - Lifetime
-
2001
- 2001-11-23 HK HK01108294A patent/HK1039633A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU9568698A (en) | 2000-04-03 |
ES2286857T3 (es) | 2007-12-01 |
EP1109926A1 (de) | 2001-06-27 |
US5851818A (en) | 1998-12-22 |
DE69837819D1 (de) | 2007-07-05 |
JP2002525270A (ja) | 2002-08-13 |
DE69837819T2 (de) | 2008-01-31 |
CA2342292A1 (en) | 2000-03-23 |
WO2000015825A1 (en) | 2000-03-23 |
HK1039633A1 (en) | 2002-05-03 |
EP1109926B1 (de) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69837819D1 (de) | Kondensierte plasmid-liposome komplex zur transfektion | |
ATE209902T1 (de) | Neue liposomkomplexe mit erhöhter systemischer verabreichung | |
DE69906977D1 (de) | In liposomen verkapselte nukleinsäurekomplexe | |
WO1998019709A3 (en) | Cationic reagents for transfection | |
EP0759694A4 (de) | Verfahren zur in-vivo abgabe therapeutischer agenzien mittels liposomen | |
ATE322255T1 (de) | Polyamid-oligomere | |
AU4711296A (en) | Method for loading lipid vesicles | |
DE69730218D1 (de) | Fusogene liposomen | |
WO1997030024A3 (de) | Lipidverbindungen und deren verwendung z.b. in liposomen | |
NZ513829A (en) | Encapsulation of bioactive complexes in liposomes | |
DK0734252T3 (da) | Vincaalkaloidvesikler med forøget effektivitet og tumormålsøgningsegenskaber | |
WO2001049266A3 (en) | Iron chelator delivery system | |
ES2185418T3 (es) | Agentes previstos para tratar tumores, basados en liposomas y que contienen tamoxifeno. | |
EP1231895A4 (de) | Modulares zielgerichtetes liposomales verabreichungssytem | |
WO2000045845A3 (en) | Liposome composition and method for administration of a radiosensitizer | |
WO2001078785A3 (de) | Wirkstoff-konjugate mit intrazellulär wirksamen liganden | |
WO1999064439A3 (en) | Methods for increasing cationic antimicrobial peptides | |
BR9811579B1 (pt) | ácidos 3-ciano-2,4-dialógeno-5-fluorobenzóicos e processo para a preparação dos mesmos. | |
EA200100269A1 (ru) | Иммуногенные липосомные композиции | |
DE3851842D1 (de) | Wässrige bereitung von liposomenzusammensetzungen. | |
DE69520231D1 (de) | Liposomzubereitungen enthaltend hybrid-interferon | |
WO2000074646A3 (de) | Neue liposomale vektorkomplexe und deren verwendung für die gentherapie | |
US20030003584A1 (en) | Liposomal vector binding protein for hepatocyte DNA delivery | |
UA25289C2 (uk) | Спосіб приготування горілки "імператорська" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |